Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Int J Infect Dis ; 147: 107173, 2024 Oct.
Article in English | MEDLINE | ID: mdl-39094762

ABSTRACT

OBJECTIVES: We studied the immunogenicity after primary and booster vaccinations of the Abdala COVID-19 vaccine, a receptor-binding domain protein subunit vaccine, in Vietnamese people by determining the level of neutralization and cross-neutralization activities against the ancestral SARS-CoV-2 and its variants and SARS-CoV-1. METHODS: We performed a prospective observational study, enrolling adults aged 19-59 years in Dong Thap province, southern Vietnam, and collected blood samples from baseline until 4 weeks after the booster dose. We measured anti-nucleocapsid, anti-spike, and neutralizing antibodies against SARS-CoV-2 and assessed the cross-neutralization against 14 SARS-CoV-2 variants and SARS-CoV-1. Complementary antibody data came from Vietnamese health care workers fully vaccinated with ChAdOx1-S. RESULTS: After primary vaccination, anti-spike antibody and neutralizing antibodies were detectable in 98.4% and 87% of 251 study participants, respectively, with neutralizing antibody titers similar to that induced by ChAdOx1-S vaccine. Antibody responses after a homologous (Abdala COVID-19) or heterologous (messenger RNA BNT162b2) booster could neutralize 14 SARS-CoV-2 variants (including Omicron) and SARS-CoV-1. CONCLUSIONS: Abdala COVID-19 vaccine is immunogenic in Vietnamese people. Enhanced antibody response after a booster dose could cross-neutralize 14 SARS-CoV-2 variants and SARS-CoV-1. Our results have added to the growing body of knowledge about the contribution of protein subunit vaccine platforms to pandemic control.


Subject(s)
Antibodies, Neutralizing , Antibodies, Viral , COVID-19 Vaccines , COVID-19 , Immunization, Secondary , SARS-CoV-2 , Humans , Vietnam , Adult , Prospective Studies , Female , Male , Antibodies, Neutralizing/blood , SARS-CoV-2/immunology , Middle Aged , COVID-19/prevention & control , COVID-19/immunology , COVID-19/epidemiology , Antibodies, Viral/blood , COVID-19 Vaccines/immunology , COVID-19 Vaccines/administration & dosage , Young Adult , Immunogenicity, Vaccine , ChAdOx1 nCoV-19/immunology , Spike Glycoprotein, Coronavirus/immunology , Vaccination , Southeast Asian People
3.
Emerg Infect Dis ; 29(5): 1002-1006, 2023 05.
Article in English | MEDLINE | ID: mdl-37015283

ABSTRACT

We analyzed 1,303 SARS-CoV-2 whole-genome sequences from Vietnam, and found the Alpha and Delta variants were responsible for a large nationwide outbreak of COVID-19 in 2021. The Delta variant was confined to the AY.57 lineage and caused >1.7 million infections and >32,000 deaths. Viral transmission was strongly affected by nonpharmaceutical interventions.


Subject(s)
COVID-19 , Humans , COVID-19/epidemiology , SARS-CoV-2/genetics , Vietnam/epidemiology , Disease Outbreaks
4.
Vaccine ; 41(13): 2208-2213, 2023 03 24.
Article in English | MEDLINE | ID: mdl-36849339

ABSTRACT

BACKGROUND: Ongoing tetanus cases and sporadic outbreaks of vaccine-preventable diseases associated with routine vaccination programmes remain problems in many low and middle-income countries, including Vietnam. With no human-to-human transmission or natural immunity, tetanus antibody levels indicate both individual risk of tetanus and gaps in vaccination programmes. METHODS: To investigate gaps in immunity to tetanus in Vietnam, a country with a historically high level of tetanus vaccination coverage, tetanus antibodies were measure by ELISA from samples selected from a long-term serum bank, established for the purposes of general-population seroepidemiological investigations in southern Vietnam. Samples were selected from 10 provinces, focussing on age-groups targeted by national vaccination programmes for infants and pregnant women (Expanded Programme on Immunization, EPI, and Maternal and Neonatal Tetanus, MNT). RESULTS: Antibodies were measured from a total of 3864 samples. Highest tetanus antibody concentrations occurred in children under 4 years old, over 90 % of whom had protective levels. Approximately 70 % of children aged 7-12 years had protective antibody concentrations although there was variation among provinces. For infants and children, there were no significant differences in tetanus protection between males and females, but for adults aged 20-35 years, in five of the ten provinces surveyed, protection against tetanus was higher in females (p < 0.05) who are eligible for booster doses under the MNT programme. In seven of ten provinces, antibody concentrations were inversely related to age (p < 0.01) and protection of older individuals was generally low. CONCLUSION: Widespread immunity to tetanus toxoid is seen in infants and young children consistent with the high coverage rates reported for diptheria tetanus toxoid and pertussis (DTP) in Vietnam. However, the lower antibody concentrations seen in older children and men suggest reduced immunity to tetanus in populations not targeted by EPI and MNT programmes.


Subject(s)
Tetanus , Male , Infant , Child , Adult , Infant, Newborn , Humans , Female , Pregnancy , Child, Preschool , Tetanus/prevention & control , Vietnam/epidemiology , Tetanus Toxoid , Vaccination , Antibodies, Bacterial , Diphtheria-Tetanus-Pertussis Vaccine
5.
Am J Trop Med Hyg ; 108(1): 137-144, 2023 01 11.
Article in English | MEDLINE | ID: mdl-36450229

ABSTRACT

We studied the development and persistence of neutralizing antibodies against SARS-CoV-2 ancestral strain, and Delta and Omicron (BA.1 and BA.2) variants in Vietnamese healthcare workers (HCWs) up to 15 weeks after booster vaccination. We included 47 HCWs, including group 1 (G1, N = 21) and group 2 (G2; N = 26) without and with breakthrough Delta variant infection before booster immunization, respectively). The study participants had completed primary immunization with ChAdOx1-S and booster vaccination with BNT162b2. Neutralizing antibodies were measured using a surrogate virus neutralization assay. Of the 21 study participants in G1, neutralizing antibodies against ancestral strain, Delta variant, BA.1, and BA.2 were (almost) abolished at month 8 after the second dose, but all had detectable neutralizing antibodies to the study viruses at week 2 post booster dose. Of the 26 study participants in G2, neutralizing antibody levels to BA.1 and BA.2 were significantly higher than those to the corresponding viruses measured at week 2 post breakthrough infection and before the booster dose. At week 15 post booster vaccination, neutralizing antibodies to BA.1 and BA.2 dropped significantly, with more profound changes observed in those without breakthrough Delta variant infection. Booster vaccination enhanced neutralizing activities against ancestral strain and Delta variant compared with those induced by primary vaccination. These responses were maintained at high levels for at least 15 weeks. Our findings emphasize the importance of the first booster dose in producing cross-neutralizing antibodies against Omicron variant. A second booster to maintain long-term vaccine effectiveness against the currently circulating variants merits further research.


Subject(s)
BNT162 Vaccine , COVID-19 , Humans , Antibodies, Neutralizing , Kinetics , Immunization, Secondary , Southeast Asian People , COVID-19/prevention & control , SARS-CoV-2/genetics , Vaccination , ChAdOx1 nCoV-19 , Breakthrough Infections , Health Personnel , Antibodies, Viral
6.
Microb Genom ; 7(2)2021 02.
Article in English | MEDLINE | ID: mdl-33502303

ABSTRACT

Pre-existing colonization with Staphylococcus aureus or Klebsiella pneumoniae has been found to increase the risk of infection in intensive care patients. We previously conducted a longitudinal study to characterize colonization of these two organisms in patients admitted to intensive care in a hospital in southern Vietnam. Here, using genomic and phylogenetic analyses, we aimed to assess the contribution these colonizing organisms made to infections. We found that in the majority of patients infected with S. aureus or K. pneumoniae, the sequence type of the disease-causing (infecting) isolate was identical to that of corresponding colonizing organisms in the respective patient. Further in-depth analysis revealed that in patients infected by S. aureus ST188 and by K. pneumoniae ST17, ST23, ST25 and ST86, the infecting isolate was closely related to and exhibited limited genetic variation relative to pre-infection colonizing isolates. Multidrug-resistant S. aureus ST188 was identified as the predominant agent of colonization and infection. Colonization and infection by K. pneumoniae were characterized by organisms with limited antimicrobial resistance profiles but extensive repertoires of virulence genes. Our findings augment the understanding of the link between bacterial colonization and infection in a low-resource setting, and could facilitate the development of novel evidence-based approaches to prevent and treat infections in high-risk patients in intensive care.


Subject(s)
Drug Resistance, Multiple, Bacterial , Klebsiella Infections/microbiology , Klebsiella pneumoniae/classification , Staphylococcal Infections/microbiology , Staphylococcus aureus/classification , Adult , Aged , Female , High-Throughput Nucleotide Sequencing , Humans , Intensive Care Units , Klebsiella pneumoniae/genetics , Klebsiella pneumoniae/isolation & purification , Male , Microbial Sensitivity Tests , Middle Aged , Phylogeny , Prospective Studies , Staphylococcus aureus/genetics , Staphylococcus aureus/isolation & purification , Vietnam , Whole Genome Sequencing
7.
Am J Trop Med Hyg ; 96(1): 93-96, 2017 Jan 11.
Article in English | MEDLINE | ID: mdl-27821690

ABSTRACT

In Vietnam, there are no accurate data on tetanus incidence to allow assessment of disease burden or vaccination program efficacy. We analyzed age structure of 786 tetanus cases admitted to a tertiary referral center in Vietnam for three separate years during an 18-year period to examine the impact of tetanus prevention programs, namely the Expanded Program on Immunization (EPI) and the Maternal and Neonatal Tetanus (MNT) initiative. Most cases were born before the initiation of EPI. Median age increased from 33 (interquartile range: 20-52) in 1994, to 46 (32-63) in 2012 (P < 0.001). Birth-year distribution was unchanged, indicating the same birth cohorts presented with tetanus in 1994, 2003, and 2012. Enzyme-linked immunosorbent assay measurements in 90 men and 90 women covered by MNT but not EPI showed 73.3% (95% confidence interval [CI]: 62.9-82.1%) of women had anti-tetanus antibody compared with 24.4% (95% CI: 15.9-34.7%) of men, indicating continued tetanus vulnerability in older men in Vietnam.


Subject(s)
Tetanus Toxoid/immunology , Tetanus/epidemiology , Tetanus/prevention & control , Adult , Enzyme-Linked Immunosorbent Assay , Female , Humans , Male , Middle Aged , Public Health Administration , Tetanus Toxoid/administration & dosage , Vaccination , Vietnam/epidemiology , Young Adult
8.
Am J Trop Med Hyg ; 92(5): 1045-52, 2015 May.
Article in English | MEDLINE | ID: mdl-25802437

ABSTRACT

We performed a prospective multicenter study to address the lack of data on the etiology, clinical and demographic features of hospitalized pediatric diarrhea in Ho Chi Minh City (HCMC), Vietnam. Over 2,000 (1,419 symptomatic and 609 non-diarrheal control) children were enrolled in three hospitals over a 1-year period in 2009-2010. Aiming to detect a panel of pathogens, we identified a known diarrheal pathogen in stool samples from 1,067/1,419 (75.2%) children with diarrhea and from 81/609 (13.3%) children without diarrhea. Rotavirus predominated in the symptomatic children (664/1,419; 46.8%), followed by norovirus (293/1,419; 20.6%). The bacterial pathogens Salmonella, Campylobacter, and Shigella were cumulatively isolated from 204/1,419 (14.4%) diarrheal children and exhibited extensive antimicrobial resistance, most notably to fluoroquinolones and third-generation cephalosporins. We suggest renewed efforts in generation and implementation of policies to control the sale and prescription of antimicrobials to curb bacterial resistance and advise consideration of a subsidized rotavirus vaccination policy to limit the morbidity due to diarrheal disease in Vietnam.


Subject(s)
Bacterial Infections/epidemiology , Caliciviridae Infections/epidemiology , Diarrhea/complications , Norovirus/isolation & purification , Rotavirus Infections/epidemiology , Anti-Infective Agents/pharmacology , Bacteria/drug effects , Bacterial Infections/complications , Bacterial Infections/microbiology , Caliciviridae Infections/complications , Caliciviridae Infections/microbiology , Child, Preschool , Cross-Sectional Studies , Demography , Diarrhea/epidemiology , Diarrhea/microbiology , Female , Hospitalization , Humans , Infant , Male , Microbial Sensitivity Tests , Norovirus/drug effects , Prospective Studies , Rotavirus/drug effects , Rotavirus/isolation & purification , Rotavirus Infections/complications , Rotavirus Infections/microbiology , Seasons , Vietnam/epidemiology
9.
J Med Microbiol ; 63(Pt 10): 1386-1394, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25038137

ABSTRACT

Ventilator-associated pneumonia (VAP) is a serious healthcare-associated infection that affects up to 30 % of intubated and mechanically ventilated patients in intensive care units (ICUs) worldwide. The bacterial aetiology and corresponding antimicrobial susceptibility of VAP is highly variable, and can differ between countries, national provinces and even between different wards in the same hospital. We aimed to understand and document changes in the causative agents of VAP and their antimicrobial susceptibility profiles retrospectively over an 11 year period in a major infectious disease hospital in southern Vietnam. Our analysis outlined a significant shift from Pseudomonas aeruginosa to Acinetobacter spp. as the most prevalent bacteria isolated from quantitative tracheal aspirates in patients with VAP in this setting. Antimicrobial resistance was common across all bacterial species and we found a marked proportional annual increase in carbapenem-resistant Acinetobacter spp. over a 3 year period from 2008 (annual trend; odds ratio 1.656, P = 0.010). We further investigated the possible emergence of a carbapenem-resistant Acinetobacter baumannii clone by multiple-locus variable number tandem repeat analysis, finding a blaOXA-23-positive strain that was associated with an upsurge in the isolation of this pathogen. We additionally identified a single blaNDM-1-positive A. baumannii isolate. This work highlights the emergence of a carbapenem-resistant clone of A. baumannii and a worrying trend of antimicrobial resistance in the ICU of the Hospital for Tropical Diseases in Ho Chi Minh City, Vietnam.


Subject(s)
Acinetobacter Infections/microbiology , Acinetobacter baumannii/drug effects , Carbapenems/pharmacology , Pneumonia, Ventilator-Associated/microbiology , beta-Lactam Resistance , Acinetobacter Infections/epidemiology , Acinetobacter baumannii/isolation & purification , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , Female , Genotype , Hospitals , Humans , Intensive Care Units , Male , Middle Aged , Molecular Epidemiology , Multilocus Sequence Typing , Pneumonia, Ventilator-Associated/epidemiology , Prevalence , Retrospective Studies , Vietnam/epidemiology , Young Adult
10.
Proc Natl Acad Sci U S A ; 110(43): 17522-7, 2013 Oct 22.
Article in English | MEDLINE | ID: mdl-24082120

ABSTRACT

Shigella sonnei is a human-adapted pathogen that is emerging globally as the dominant agent of bacterial dysentery. To investigate local establishment, we sequenced the genomes of 263 Vietnamese S. sonnei isolated over 15 y. Our data show that S. sonnei was introduced into Vietnam in the 1980s and has undergone localized clonal expansion, punctuated by genomic fixation events through periodic selective sweeps. We uncover geographical spread, spatially restricted frontier populations, and convergent evolution through local gene pool sampling. This work provides a unique, high-resolution insight into the microevolution of a pioneering human pathogen during its establishment in a new host population.


Subject(s)
Dysentery, Bacillary/epidemiology , Endemic Diseases , Genetic Variation , Shigella sonnei/genetics , Anti-Bacterial Agents/therapeutic use , Child , Child, Preschool , Chromosomes, Bacterial/genetics , Ciprofloxacin/therapeutic use , Dysentery, Bacillary/drug therapy , Dysentery, Bacillary/microbiology , Evolution, Molecular , Fluoroquinolones/therapeutic use , Gatifloxacin , Genome, Bacterial/genetics , Genomics/methods , Geography , Humans , Infant , Molecular Sequence Data , Mutation Rate , Phylogeny , Sequence Analysis, DNA , Shigella sonnei/classification , Shigella sonnei/physiology , Vietnam/epidemiology
11.
Emerg Infect Dis ; 19(6): 977-80, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23735160

ABSTRACT

We performed a case-control investigation to identify risk factors for norovirus infections among children in Vietnam. Of samples from 1,419 children who had diarrhea and 609 who were asymptomatic, 20.6% and 2.8%, respectively, were norovirus positive. Risk factors included residential crowding and symptomatic contacts, indicating person-to-person transmission of norovirus.


Subject(s)
Caliciviridae Infections/epidemiology , Diarrhea/epidemiology , Gastroenteritis/epidemiology , Norovirus , Caliciviridae Infections/history , Caliciviridae Infections/transmission , Case-Control Studies , Child , Diarrhea/history , Diarrhea/virology , Gastroenteritis/history , Gastroenteritis/virology , History, 21st Century , Humans , Norovirus/classification , Norovirus/genetics , Norovirus/isolation & purification , Prevalence , Prospective Studies , Risk Factors , Seasons , Vietnam/epidemiology
12.
Infect Genet Evol ; 18: 335-43, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23612321

ABSTRACT

Norovirus (NoV) is a major cause of epidemic gastroenteritis in industrialized countries, yet the epidemiological significance of NoV in industrializing countries remains poorly understood. The spatiotemporal distribution of NoV genotypes identified in 2054 enrolled children was investigated between May 2009 and December 2010, in Ho Chi Minh City (HCMC), Vietnam. A total of 315 NoV extracted from stool samples were genotyped and GPS mapped to their source. Genogroup II NoV, particularly GII.4, were predominant, and the GII.4 strains could be subgrouped into GII.4-2006b (Minerva) and GII.4-2010 (New Orleans) variants. There was no spatiotemporal structure among the endemic GII strains; yet a significant spatiotemporal signal corresponding with the novel introduction of GII.4-2010 variant was detected. These data show that NoV GII.4 variants are highly endemic in HCMC and describe a scenario of rapid NoV strain replacement occurring in HCMC in early 2010.


Subject(s)
Caliciviridae Infections/virology , Gastroenteritis/virology , Norovirus/classification , Child, Preschool , Cluster Analysis , Feces/virology , Genotype , Geographic Information Systems , Humans , Infant , Infant, Newborn , Norovirus/genetics , Norovirus/isolation & purification , Phylogeography , Spatio-Temporal Analysis , Vietnam
13.
J Virol Methods ; 187(1): 138-43, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23046990

ABSTRACT

Rotavirus (RoV) and Norovirus (NoV) are the main causes of viral gastroenteritis. Currently, there is no validated multiplex real-time PCR that can detect and quantify RoV and NoV simultaneously. The aim of the study was to develop, validate, and internally control a multiplex one-step RT real-time PCR to detect and quantify RoV and NoV in stool samples. PCR sensitivity was assessed by comparing amplification against the current gold standard, enzyme immunoassay (EIA), on stool samples from 94 individuals with diarrhea and 94 individuals without diarrhea. PCR detected 10% more RoV positive samples than EIA in stools samples from patients with diarrhea. PCR detected 23% more NoV genogroup II positive samples from individuals with diarrhea and 9% more from individuals without diarrhea than EIA, respectively. Genotyping of the PCR positive/EIA negative samples suggested the higher rate of PCR positivity, in comparison to EIA, was due to increased sensitivity, rather than nonspecific hybridization. Quantitation demonstrated that the viral loads of RoV and NoV in the stools of diarrheal patients were an order of magnitude greater than in individuals without diarrhea. This internally controlled real-time PCR method is robust, exhibits a high degree of reproducibility, and may have a greater utility and sensitivity than commercial EIA kits.


Subject(s)
Caliciviridae Infections/diagnosis , Multiplex Polymerase Chain Reaction , Norovirus/isolation & purification , Real-Time Polymerase Chain Reaction , Rotavirus Infections/diagnosis , Rotavirus/isolation & purification , Caliciviridae Infections/virology , Child, Preschool , Diarrhea/diagnosis , Diarrhea/virology , Feces/virology , Gastroenteritis/diagnosis , Gastroenteritis/genetics , Genotype , Humans , Infant , Infant, Newborn , Norovirus/genetics , RNA, Viral/analysis , Reproducibility of Results , Reverse Transcriptase Polymerase Chain Reaction , Rotavirus/genetics , Rotavirus Infections/virology
14.
PLoS Negl Trop Dis ; 5(8): e1264, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21829747

ABSTRACT

BACKGROUND: The bacterial genus Shigella is the leading cause of dysentery. There have been significant increases in the proportion of Shigella isolated that demonstrate resistance to nalidixic acid. While nalidixic acid is no longer considered as a therapeutic agent for shigellosis, the fluoroquinolone ciprofloxacin is the current recommendation of the World Health Organization. Resistance to nalidixic acid is a marker of reduced susceptibility to older generation fluoroquinolones, such as ciprofloxacin. We aimed to assess the efficacy of gatifloxacin versus ciprofloxacin in the treatment of uncomplicated shigellosis in children. METHODOLOGY/PRINCIPAL FINDINGS: We conducted a randomized, open-label, controlled trial with two parallel arms at two hospitals in southern Vietnam. The study was designed as a superiority trial and children with dysentery meeting the inclusion criteria were invited to participate. Participants received either gatifloxacin (10 mg/kg/day) in a single daily dose for 3 days or ciprofloxacin (30 mg/kg/day) in two divided doses for 3 days. The primary outcome measure was treatment failure; secondary outcome measures were time to the cessation of individual symptoms. Four hundred and ninety four patients were randomized to receive either gatifloxacin (n=249) or ciprofloxacin (n=245), of which 107 had a positive Shigella stool culture. We could not demonstrate superiority of gatifloxacin and observed similar clinical failure rate in both groups (gatifloxacin; 12.0% and ciprofloxacin; 11.0%, p=0.72). The median (inter-quartile range) time from illness onset to cessation of all symptoms was 95 (66-126) hours for gatifloxacin recipients and 93 (68-120) hours for the ciprofloxacin recipients (Hazard Ratio [95%CI]=0.98 [0.82-1.17], p=0.83). CONCLUSIONS: We conclude that in Vietnam, where nalidixic acid resistant Shigellae are highly prevalent, ciprofloxacin and gatifloxacin are similarly effective for the treatment of acute shigellosis.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Ciprofloxacin/therapeutic use , Dysentery, Bacillary/drug therapy , Fluoroquinolones/therapeutic use , Shigella/isolation & purification , Anti-Bacterial Agents/adverse effects , Child, Preschool , Dysentery, Bacillary/blood , Dysentery, Bacillary/metabolism , Feces/microbiology , Female , Fluoroquinolones/adverse effects , Gatifloxacin , Hospitals , Humans , Hyperglycemia/microbiology , Hypoglycemia/microbiology , Infant , Male , Proportional Hazards Models , Treatment Outcome , Vietnam
15.
BMC Infect Dis ; 9: 204, 2009 Dec 15.
Article in English | MEDLINE | ID: mdl-20003464

ABSTRACT

BACKGROUND: Shigellosis remains considerable public health problem in some developing countries. The nature of Shigellae suggests that they are highly adaptable when placed under selective pressure in a human population. This is demonstrated by variation and fluctuations in serotypes and antimicrobial resistance profile of organisms circulating in differing setting in endemic locations. Antimicrobial resistance in the genus Shigella is a constant threat, with reports of organisms in Asia being resistant to multiple antimicrobials and new generation therapies. METHODS: Here we compare microbiological, clinical and epidemiological data from patients with shigellosis over three different periods in southern Vietnam spanning 14 years. RESULTS: Our data demonstrates a shift in dominant infecting species (S. flexneri to S. sonnei) and resistance profile of the organisms circulating in southern Vietnam. We find that there was no significant variation in the syndromes associated with either S. sonnei or S. flexneri, yet the clinical features of the disease are more severe in later observations. CONCLUSIONS: Our findings show a change in clinical presentation of shigellosis in this setting, as the disease may be now more pronounced, this is concurrent with a change in antimicrobial resistance profile. These data highlight the socio-economic development of southern Vietnam and should guide future vaccine development and deployment strategies. TRIAL REGISTRATION: Current Controlled Trials ISRCTN55945881.


Subject(s)
Dysentery, Bacillary/epidemiology , Dysentery, Bacillary/microbiology , Child, Preschool , Drug Resistance, Multiple, Bacterial , Female , Humans , Infant , Male , Microbial Sensitivity Tests , Seasons , Serotyping , Shigella flexneri/classification , Shigella flexneri/drug effects , Shigella flexneri/pathogenicity , Shigella sonnei/classification , Shigella sonnei/drug effects , Shigella sonnei/pathogenicity , Vietnam/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL